BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1359832)

  • 1. Toremifene resistance in a rat mammary tumour model.
    Kellen JA; Georges E; Ling V; Dubsky M
    Anticancer Res; 1992; 12(5):1663-5. PubMed ID: 1359832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical determination of P-glycoprotein in a rat mammary tumour treated with tamoxifen.
    Kellen JA; Wong AC; Mirakian A
    In Vivo; 1992; 6(5):541-4. PubMed ID: 1360843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased P-glycoprotein in a tamoxifen-tolerant breast carcinoma model.
    Kellen JA; George E; Ling V
    Anticancer Res; 1991; 11(3):1243-4. PubMed ID: 1679618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. R-verapamil decreases anti-estrogen resistance in a breast cancer model.
    Kellen JA; Wong A; Georges E; Ling V
    Anticancer Res; 1991; 11(2):809-11. PubMed ID: 1676580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of toremifene on the expression of genes in a rat mammary adenocarcinoma.
    Kellen JA; Mirakian A
    In Vivo; 1996; 10(5):511-3. PubMed ID: 8899431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen tolerance and steroid receptors in a tumor model.
    Kellen JA; Sutherland DJ
    In Vivo; 1988; 2(3-4):299-300. PubMed ID: 2979847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid growth suppression response in 13762NF adenocarcinoma-derived Con8 rat mammary tumor cells is mediated by dominant trans-acting factors.
    Webster MK; Guthrie J; Firestone GL
    Cancer Res; 1991 Nov; 51(22):6031-8. PubMed ID: 1933866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The multidrug-resistance modifiers verapamil, cyclosporine A and tamoxifen induce an intracellular acidification in colon carcinoma cell lines in vitro.
    Hamilton G; Cosentini EP; Teleky B; Koperna T; Zacheri J; Riegler M; Feil W; Schiessel R; Wenzi E
    Anticancer Res; 1993; 13(6A):2059-63. PubMed ID: 7905252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An antiangiogenic urokinase-derived peptide combined with tamoxifen decreases tumor growth and metastasis in a syngeneic model of breast cancer.
    Guo Y; Mazar AP; Lebrun JJ; Rabbani SA
    Cancer Res; 2002 Aug; 62(16):4678-84. PubMed ID: 12183425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiestrogenic action of toremifene on hormone-dependent, -independent, and heterogeneous breast tumor growth in the athymic mouse.
    Robinson SP; Jordan VC
    Cancer Res; 1989 Apr; 49(7):1758-62. PubMed ID: 2522347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGF receptors in R3230AC rat mammary carcinomas: characteristics and regulation in vitro and in vivo.
    Ryan PD; Hilf R
    Oncol Res; 1992; 4(4-5):181-92. PubMed ID: 1504378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The in vitro combination-effect of toremifene with CAF (cyclophosphamide, adriamycin, 5-fluorouracil) on growth of various human mammary carcinomas].
    Kuroiwa S; Maruyama S; Okada M; Abe F
    Gan To Kagaku Ryoho; 1998 Aug; 25(10):1581-9. PubMed ID: 9725052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of toremifene and its main metabolites on growth of breast cancer cell lines.
    Coradini D; Biffi A; Cappelletti V; Di Fronzo G
    Anticancer Res; 1991; 11(6):2191-7. PubMed ID: 1837981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Synergistic effect of toremifene and cisplatin on human lung cancer cell line A549].
    Zhang X; Li Q; Han Y; Liu Z
    Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):537-9. PubMed ID: 12667319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of estradiol and tamoxifen on the growth of N-nitrosomethylurea-induced rat mammary tumor cells in soft agar.
    Arafah BM; Gordon NH; Wilhite BL; Pearson OH
    Cancer Res; 1984 Jul; 44(7):2869-72. PubMed ID: 6722815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toremifene enhances cell cycle block and growth inhibition by vinblastine in multidrug resistant human breast cancer cells.
    Baker WJ; Maenpaa JU; Wurz GT; Koester SK; Seymour RC; Emshoff VD; Wiebe VJ; DeGregorio MW
    Oncol Res; 1993; 5(6-7):207-12. PubMed ID: 8123940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-proliferative effect of toremifene and tamoxifen on estrogen receptor-lacking anaplastic thyroid carcinoma cell lines.
    Kishino T; Watanabe M; Kimura M; Sugawara I
    Biol Pharm Bull; 1997 Dec; 20(12):1257-60. PubMed ID: 9448099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoids coordinately disrupt a transforming growth factor alpha autocrine loop and suppress the growth of 13762NF-derived Con8 rat mammary adenocarcinoma cells.
    Alexander DB; Goya L; Webster MK; Haraguchi T; Firestone GL
    Cancer Res; 1993 Apr; 53(8):1808-15. PubMed ID: 8467499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uterotrophic effects of tamoxifen, toremifene, and raloxifene do not predict endometrial cell proliferation in the ovariectomized CD1 mouse.
    Carthew P; Edwards RE; Nolan BM
    Toxicol Appl Pharmacol; 1999 Jul; 158(1):24-32. PubMed ID: 10387929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of protein kinase C in human renal cell carcinoma cells with inherent resistance to doxorubicin.
    Efferth T; Volm M
    Anticancer Res; 1992; 12(6B):2209-11. PubMed ID: 1363517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.